BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24100678)

  • 1. JNK inhibitor SP600125 enhances TGF-β-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner.
    Lin Y; Zhang B; Liang H; Lu Y; Ai X; Zhang B; Chen X
    Mol Med Rep; 2013 Dec; 8(6):1623-9. PubMed ID: 24100678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of JNK enhances TGF-beta1-activated Smad2 signaling in mouse embryonic lung.
    Wu S; Kasisomayajula K; Peng J; Bancalari E
    Pediatr Res; 2009 Apr; 65(4):381-6. PubMed ID: 19127219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa.
    Biasi F; Vizio B; Mascia C; Gaia E; Zarkovic N; Chiarpotto E; Leonarduzzi G; Poli G
    Free Radic Biol Med; 2006 Aug; 41(3):443-54. PubMed ID: 16843825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.
    Wang S; Yin J; Ge M; Dai Z; Li Y; Si J; Ma K; Li L; Yao S
    Biomed Pharmacother; 2016 Mar; 78():280-290. PubMed ID: 26898453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
    Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
    Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAPK/JNK plays a role in transforming growth factor-beta-induced VEGF synthesis in osteoblasts.
    Kanno Y; Ishisaki A; Yoshida M; Tokuda H; Numata O; Kozawa O
    Horm Metab Res; 2005 Mar; 37(3):140-5. PubMed ID: 15824967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
    Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
    Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 22 (HSPB8) limits TGF-β-stimulated migration of osteoblasts.
    Yamamoto N; Tokuda H; Kuroyanagi G; Kainuma S; Matsushima-Nishiwaki R; Fujita K; Kozawa O; Otsuka T
    Mol Cell Endocrinol; 2016 Nov; 436():1-9. PubMed ID: 27396899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.
    Vayalil PK; Iles KE; Choi J; Yi AK; Postlethwait EM; Liu RM
    Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1281-92. PubMed ID: 17890327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SP600125, an inhibitor of c-Jun NH2-terminal kinase, blocks expression of angiotensin II-induced monocyte chemoattractant protein-1 in human mesangial cells.
    Ding GX; Zhang AH; Huang SM; Pan XQ; Chen RH
    World J Pediatr; 2010 May; 6(2):169-76. PubMed ID: 20490773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the JNK signaling in granular corneal dystrophy by modulating TGF-β-induced TGFBI expression and corneal fibroblast apoptosis.
    Nie D; Liu X; Wang Y; He W; Li M; Peng Y; Zhang J; Sun L; Yan Z; Ye L
    In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):234-242. PubMed ID: 32189173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.
    Nagata H; Hatano E; Tada M; Murata M; Kitamura K; Asechi H; Narita M; Yanagida A; Tamaki N; Yagi S; Ikai I; Matsuzaki K; Uemoto S
    Hepatology; 2009 Jun; 49(6):1944-53. PubMed ID: 19418558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
    Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model.
    Konno T; Ninomiya T; Kohno T; Kikuchi S; Sawada N; Kojima T
    Histochem Cell Biol; 2015 May; 143(5):471-9. PubMed ID: 25511417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
    Qureshi HY; Ricci G; Zafarullah M
    Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis.
    Guan QH; Pei DS; Liu XM; Wang XT; Xu TL; Zhang GY
    Brain Res; 2006 May; 1092(1):36-46. PubMed ID: 16674927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.
    Wei K; Li M; Zöller M; Wang M; Mehrabi A; Hoffmann K
    Cell Death Dis; 2019 Mar; 10(3):231. PubMed ID: 30850583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions.
    Mori S; Matsuzaki K; Yoshida K; Furukawa F; Tahashi Y; Yamagata H; Sekimoto G; Seki T; Matsui H; Nishizawa M; Fujisawa J; Okazaki K
    Oncogene; 2004 Sep; 23(44):7416-29. PubMed ID: 15326485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells.
    Liu Q; Mao H; Nie J; Chen W; Yang Q; Dong X; Yu X
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S88-95. PubMed ID: 18552272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.